{"id":"https://openalex.org/W2001461684","doi":"https://doi.org/10.1115/sbc2012-80799","title":"The Mechanical and Structural Changes in Murine Arteries due to the Antiretroviral Drug Azidothymidine (AZT)","display_name":"The Mechanical and Structural Changes in Murine Arteries due to the Antiretroviral Drug Azidothymidine (AZT)","publication_year":2012,"publication_date":"2012-06-20","ids":{"openalex":"https://openalex.org/W2001461684","doi":"https://doi.org/10.1115/sbc2012-80799","mag":"2001461684"},"language":"en","primary_location":{"id":"doi:10.1115/sbc2012-80799","doi":"https://doi.org/10.1115/sbc2012-80799","is_oa":false,"landing_page_url":"https://doi.org/10.1115/sbc2012-80799","pdf_url":null,"source":{"id":"https://openalex.org/S4306503435","display_name":"ASME Summer Bioengineering Conference (SBC)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"conference"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASME 2012 Summer Bioengineering Conference, Parts A and B","raw_type":"proceedings-article"},"volume":null,"type":"conference-paper","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020809156","display_name":"Laura Hansen","orcid":"https://orcid.org/0000-0002-3936-9476","observed_orcids":["https://orcid.org/0000-0002-3936-9476"]},"institutions":[{"id":"https://openalex.org/I130701444","display_name":"Georgia Institute of Technology","ror":"https://ror.org/01zkghx44","country_code":"US","type":"education","lineage":["https://openalex.org/I130701444"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Hansen","raw_affiliation_strings":["Georgia Institute of Technology, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Institute of Technology, Atlanta, GA","institution_ids":["https://openalex.org/I130701444"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032292937","display_name":"Manu O. Platt","orcid":"https://orcid.org/0000-0001-6390-4320","observed_orcids":["https://orcid.org/0000-0001-6390-4320"]},"institutions":[{"id":"https://openalex.org/I130701444","display_name":"Georgia Institute of Technology","ror":"https://ror.org/01zkghx44","country_code":"US","type":"education","lineage":["https://openalex.org/I130701444"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manu O. Platt","raw_affiliation_strings":["Georgia Institute of Technology, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Institute of Technology, Atlanta, GA","institution_ids":["https://openalex.org/I130701444"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038500274","display_name":"Roy L. Sutliff","orcid":"https://orcid.org/0000-0001-8628-6975","observed_orcids":["https://orcid.org/0000-0001-8628-6975"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4210152539","display_name":"Atlanta VA Medical Center","ror":"https://ror.org/04z89xx32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210131075","https://openalex.org/I4210149289","https://openalex.org/I4210152539"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roy L. Sutliff","raw_affiliation_strings":["Emory University/Atlanta VAMC, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University/Atlanta VAMC, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210152539"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050649061","display_name":"Rudolph L. Gleason","orcid":"https://orcid.org/0000-0002-6357-4955","observed_orcids":["https://orcid.org/0000-0002-6357-4955"]},"institutions":[{"id":"https://openalex.org/I130701444","display_name":"Georgia Institute of Technology","ror":"https://ror.org/01zkghx44","country_code":"US","type":"education","lineage":["https://openalex.org/I130701444"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rudolph L. Gleason","raw_affiliation_strings":["Georgia Institute of Technology, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Institute of Technology, Atlanta, GA","institution_ids":["https://openalex.org/I130701444"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.10915493,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"487","last_page":"488"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10924","display_name":"Cardiovascular Health and Disease Prevention","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11366","display_name":"Elasticity and Material Modeling","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":0.9610000252723694},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8080000281333923},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.44600000977516174},{"id":"https://openalex.org/keywords/arterial-stiffness","display_name":"arterial stiffness","score":0.8140000104904175},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.7630000114440918},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.8659999966621399},{"id":"https://openalex.org/keywords/cardiovascular-complications-of-hiv","display_name":"cardiovascular complications of HIV","score":0.5580000281333923},{"id":"https://openalex.org/keywords/carotid-intima-media-thickening","display_name":"carotid intima-media thickening","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8314250111579895},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7031403183937073},{"id":"https://openalex.org/C2780941825","wikidata":"https://www.wikidata.org/wiki/Q1538213","display_name":"Lipodystrophy","level":5,"score":0.6842874884605408},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6365779638290405},{"id":"https://openalex.org/C2778213512","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary artery disease","level":2,"score":0.5758952498435974},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.5753622055053711},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5102198123931885},{"id":"https://openalex.org/C2780972559","wikidata":"https://www.wikidata.org/wiki/Q550061","display_name":"Endothelial dysfunction","level":2,"score":0.46846291422843933},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.45574426651000977},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.44118767976760864},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.43019434809684753},{"id":"https://openalex.org/C113280763","wikidata":"https://www.wikidata.org/wiki/Q2326546","display_name":"Subclinical infection","level":2,"score":0.4191528558731079},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.40864062309265137},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34508955478668213},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.31623998284339905},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.27716049551963806},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1287001073360443}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1115/sbc2012-80799","doi":"https://doi.org/10.1115/sbc2012-80799","is_oa":false,"landing_page_url":"https://doi.org/10.1115/sbc2012-80799","pdf_url":null,"source":{"id":"https://openalex.org/S4306503435","display_name":"ASME Summer Bioengineering Conference (SBC)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"conference"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASME 2012 Summer Bioengineering Conference, Parts A and B","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1982681781","https://openalex.org/W2094591853","https://openalex.org/W2003663093","https://openalex.org/W2024424562","https://openalex.org/W2363916458","https://openalex.org/W2073783531","https://openalex.org/W2324434954","https://openalex.org/W2065009527","https://openalex.org/W2118354489","https://openalex.org/W2065984943"],"abstract_inverted_index":{"With":[0,52],"over":[1],"33":[2],"million":[3],"people":[4],"infected":[5],"with":[6],"the":[7,24,53],"human":[8],"immunodefeciency":[9],"virus":[10],"(HIV-1),":[11],"HIV-1":[12,38],"and":[13,26,74,84,106],"autoimmune":[14],"deficiency":[15],"syndrome":[16],"(AIDS)":[17],"is":[18],"a":[19,41,48,58],"worldwide":[20],"epidemic":[21],"[1].":[22],"However,":[23],"development":[25],"widespread":[27],"use":[28],"of":[29,61,87,94],"highly":[30],"active":[31],"antiretroviral":[32],"therapy":[33],"(HAART)":[34],"has":[35,65],"helped":[36],"transform":[37],"infection":[39],"from":[40],"terminal":[42],"disease":[43,76],"leading":[44],"to":[45,47],"AIDS":[46],"manageable":[49],"chronic":[50],"condition.":[51],"increase":[54],"in":[55],"life":[56],"expectancy,":[57],"new":[59],"set":[60],"non-AIDS":[62],"related":[63],"complications":[64],"emerged":[66],"including":[67,97],"dyslipidemia,":[68],"lipodystrophy,":[69],"insulin":[70],"resistance,":[71],"diabetes":[72],"mellitus,":[73],"cardiovascular":[75],"(CVD)":[77],"specifically":[78],"high":[79],"risks":[80],"for":[81],"myocardial":[82],"infarction[2]":[83],"increased":[85],"incidence":[86],"atherosclerosis":[88,96],"[3].":[89],"Additionally,":[90],"patients":[91],"exhibit":[92],"markers":[93],"subclinical":[95],"endothelial":[98],"dysfunction":[99],"[4],":[100],"carotid":[101],"artery":[102],"intima-media":[103],"thickening":[104],"[5],":[105],"arterial":[107],"stiffening":[108],"[4,":[109],"6].":[110]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}